Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
The inflation-adjusted cost of developing a new drug now doubles roughly every nine years. To reverse this trend, the ...
GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The joint guidance was created to ensure drug developers employ best practices when using AI.
The Brighterside of News on MSN
Scientists map a road to fairer, more inclusive drug development
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
A top federal health official is again touting the therapeutic “promise” of psychedelics such as psilocybin and MDMA—though ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...
Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...
Loyal’s application for drug approval is another step closer to potential approval through the FDA Center for Veterinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results